| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.74B | 48.63B | 46.94B | 44.81B | 42.75B | 39.54B |
| Gross Profit | 4.38B | 4.47B | 3.80B | 4.24B | 4.20B | 4.03B |
| EBITDA | 4.45B | 4.61B | 3.69B | 4.03B | 4.07B | 3.75B |
| Net Income | 2.23B | 2.39B | 2.04B | 2.28B | 2.34B | 2.26B |
Balance Sheet | ||||||
| Total Assets | 39.72B | 40.16B | 39.40B | 35.90B | 31.69B | 29.92B |
| Cash, Cash Equivalents and Short-Term Investments | 5.54B | 7.40B | 5.76B | 5.40B | 4.81B | 5.08B |
| Total Debt | 8.40B | 9.59B | 11.22B | 7.43B | 6.46B | 6.52B |
| Total Liabilities | 15.57B | 16.95B | 17.86B | 15.75B | 13.08B | 13.00B |
| Stockholders Equity | 24.14B | 23.20B | 21.54B | 20.15B | 18.61B | 16.92B |
Cash Flow | ||||||
| Free Cash Flow | 1.58B | 4.02B | -2.82B | -84.00M | 271.00M | 2.73B |
| Operating Cash Flow | 3.18B | 4.83B | 2.81B | 3.56B | 1.67B | 3.33B |
| Investing Cash Flow | -2.30B | -729.00M | -5.54B | -3.16B | -1.28B | -444.00M |
| Financing Cash Flow | -2.06B | -2.45B | 3.08B | 186.00M | -669.00M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥8.23B | 1.31 | ― | 1.67% | 2.08% | 48.38% | |
72 Outperform | ¥215.35B | 3.64 | 4.72% | 1.66% | 5.50% | -26.63% | |
70 Outperform | ¥25.15B | 10.21 | ― | 2.82% | 2.47% | 2.85% | |
69 Neutral | ¥5.92B | 9.76 | ― | 1.62% | 8.03% | 67.38% | |
64 Neutral | ¥362.15B | 11.50 | 5.53% | 4.35% | 22.07% | 86.12% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥583.35B | 5.81 | 7.44% | 2.10% | 5.58% | 114.23% |